Prenetics Global Limited (NASDAQ:PRENW – Get Free Report) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totaling 6,074 shares, a decrease of 61.8% from the September 15th total of 15,897 shares. Based on an average trading volume of 76,867 shares, the short-interest ratio is presently 0.1 days.
Prenetics Global Stock Performance
Shares of NASDAQ:PRENW traded down $0.00 during trading on Tuesday, reaching $0.01. 12,144 shares of the company were exchanged, compared to its average volume of 44,198. The business’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.01. Prenetics Global has a 12-month low of $0.01 and a 12-month high of $0.04.
Prenetics Global Company Profile
Prenetics Global Limited is a Hong Kong-based health sciences company focused on genomics, precision oncology and early cancer detection. Founded in 2014 by Danny Yeung, the company develops and commercializes genetic testing and health-information products intended to support preventive care, personalized wellness and clinical decision-making.
Its consumer health business includes CircleDNA, a direct-to-consumer genetic testing platform that provides reports related to ancestry, wellness, nutrition, fitness and disease risk.
Further Reading
- Five stocks we like better than Prenetics Global
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
